Literature DB >> 19157563

Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes.

Carol L Shields1, Pedro F Salazar, Arman Mashayekhi, Jerry A Shields.   

Abstract

PURPOSE: To evaluate the clinical features and outcomes of eyes with peripheral exudative hemorrhagic chorioretinopathy (PEHCR) simulating choroidal melanoma.
DESIGN: Noncomparative case series. PARTICIPANTS: A total of 173 eyes in 146 patients.
METHODS: Retrospective chart review. MAIN OUTCOME MEASURES: Clinical features and outcome.
RESULTS: All cases were referred for possible choroidal melanoma. The mean patient age was 80 years, 145 (99%) were Caucasian, and 98 (67%) were female. The main lesion had a mean diameter of 10 mm and mean thickness of 3 mm. The lesion was located temporally in 103 eyes (77%), involved 1 or 2 quadrants in 123 eyes (92%), and was located between the equator and the ora serrata in 119 eyes (89%). Features included subretinal hemorrhage in 134 eyes (78%), retinal exudation in 37 eyes (21%), retinal pigment epithelial (RPE) detachment in 48 eyes (28%), and sub-RPE hemorrhage in 45 eyes (26%). Peripheral RPE alterations or drusen were found in 120 ipsilateral eyes (69%) and 73 contralateral eyes (42%). Macular RPE alterations, drusen, or choroidal neovascularization was found in 83 ipsilateral eyes (48%) and 97 contralateral eyes (56%). After observation (mean 15 months), lesion regression or stability was found in 80 eyes (89%) and progression was found in 10 eyes (11%).
CONCLUSIONS: PEHCR is a hemorrhagic retinal degenerative process that simulates choroidal melanoma.

Entities:  

Mesh:

Year:  2009        PMID: 19157563     DOI: 10.1016/j.ophtha.2008.10.015

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Intravitreal bevacizumab injection for peripheral exudative hemorrhagic chorioretinopathy.

Authors:  María Socorro Alforja; Noelia Sabater; Joan Giralt; Alfredo Adán; Laura Pelegrín; Ricardo Casaroli-Marano
Journal:  Jpn J Ophthalmol       Date:  2011-06-02       Impact factor: 2.447

2.  Peripheral exudative hemorrhagic chorioretinopathy in Korean patients.

Authors:  Yun Taek Kim; Se Woong Kang; Jeong-Hee Lee; Song Ee Chung
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

3.  Peripheral choroidal neovascular membrane in a case of peripheral exudative hemorrhagic chorioretinopathy managed with combination therapy.

Authors:  Brijesh Takkar; Sangeeta Roy; Preet Kanwar Singh Sodhi; Shorya Azad; Gurkirat Singh Bajwa
Journal:  Int Ophthalmol       Date:  2016-06-16       Impact factor: 2.031

4.  Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula.

Authors:  Ira Seibel; Annette Hager; Tobias Duncker; Aline I Riechardt; Daniela Nürnberg; Julian P Klein; Matus Rehak; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-07       Impact factor: 3.117

5.  Evanescent vaso-occlusive choroidal pseudo-tumor with acute painful onset: a presumed vortex vein occlusion.

Authors:  Irmela Mantel; Ann Schalenbourg; Leonidas Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-21       Impact factor: 3.117

Review 6.  Retinal Pigment Epithelium Adenoma and Adenocarcinoma: A Review.

Authors:  Janani Sreenivasan; Pukhraj Rishi; Kalpita Das; Subramanian Krishnakumar; Jyotirmay Biswas
Journal:  Ocul Oncol Pathol       Date:  2020-12-22

7.  Clinical Features and Course of Patients with Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Zafer Cebeci; Yasemin Dere; Şerife Bayraktar; Samuray Tuncer; Nur Kır
Journal:  Turk J Ophthalmol       Date:  2016-10-17

8.  Surgical Management of Hemorrhagic Retinal Detachment Secondary to Peripheral Exudative Hemorrhagic Chorioretinopathy.

Authors:  Valmore A Semidey; Abdulaziz A Al Taisan; Patrik Schatz; Ibrahim Taskintuna; Marco Mura
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

9.  Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab.

Authors:  Kei Takayama; Tosio Enoki; Teruo Kojima; Sho Ishikawa; Masaru Takeuchi
Journal:  Clin Ophthalmol       Date:  2012-06-07

10.  Peripheral exudative hemorrhagic chorioretinopathy: a variant of polypoidal choroidal vasculopathy?

Authors:  Arman Mashayekhi; Carol L Shields; Jerry A Shields
Journal:  J Ophthalmic Vis Res       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.